http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022022392-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-11
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-424
filingDate 2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2022022392-A
titleOfInvention C. for the treatment of solid tumors in humans. novyi
abstract PROBLEM TO BE SOLVED: To treat a solid tumor in human C.I. To provide novyi. The present invention provides, among other things, methods for treating or ameliorating the effects of solid tumors present in humans. Such a method comprises C.I. Novyi colony forming unit (CFU), preferably C.I. Includes intratumoral administration of a unit dose of novyi NT CFU. Also, methods for weight loss of solid tumors present in humans, methods for removing solid tumors present in humans, methods for accurate microscopic resection of human tumor cells, one or more of humans. Methods for treating or ameliorating the effects of solid tumors that have metastasized to many sites, C.I. novyi CFU, preferably C.I. Also provided are novyi NT CFU unit doses and kits for treating or ameliorating the effects of solid tumors present in humans. [Selection diagram] None
priorityDate 2013-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22057968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10217017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467838060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466067924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412914739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422301530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468172652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467990332

Total number of triples: 41.